In this podcast episode, Will Tjernlund interviews Lew Bender, the President and CEO of Intensity Therapeutics, a biotech company focused on developing innovative cancer treatments. Lew shares his academic journey from a working-class background to prestigious institutions like MIT and Wharton, and discusses his career in biotech, leading to the creation of a novel drug delivery system that targets tumors directly. He emphasizes the importance of personalized medicine and the potential of his company's approach to improve patient outcomes while minimizing side effects. Lew's personal experiences with cancer in his family drive his passion for this work, and he expresses a commitment to helping as many patients as possible.
Nano Cap Podcast Website:
https://www.nanocappod.com/
Intensity Therapeutics Website: https://intensitytherapeutics.com/
Disclaimer:
The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.
